Picture Berlin Partner Bionnale the Annual Life Sciences Event 650x80px
Organisation › Details

HBM Healthcare Investments AG (SIX: HBMN)

HBM Healthcare Investments invests in the healthcare sector. The company holds and manages an international portfolio of promising companies in the human medicine, biotechnology, medical technology, and diagnostics sectors and related areas. Many of these companies have their lead products already available on the market or at an advanced stage of development. The portfolio companies are closely tracked and actively guided in their strategic direction. This is what makes HBM Healthcare Investments an interesting alternative to investments in big pharma and biotechnology companies. HBM Healthcare Investments, with funds under management of more than EUR 1 bn, has an international shareholder base and is listed on SIX Swiss Exchange (HBMN). *


Period Start 2012-12-19 existent
  Group HBM (Group)
  Predecessor HBM BioVentures AG
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Person Person Wicki, Andreas (HBM Healthcare Investments 201402 CEO)
  Street 1 Bundesplatz
  City 6300 Zug
  Tel +41-41-768-1108
    Address record changed: 2020-12-02
Basic data Employees n. a.
  Currency USD
  Annual sales 1,000,000,000 (funds, managed (2018) 2018-11-26)
    * Document for �About Section�: Swixx Biopharma AG. (5/20/21). "Press Release: Swixx Welcomes Mérieux Equity Partners as Minority Shareholder and Announces €45 Million Capital Increase". Baar.
Record changed: 2021-12-20


Picture [iito] Fighting Customers 650x100px

More documents for HBM (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Bionnale the Annual Life Sciences Event 650x80px

» top